The University of Oxford has launched a new initiative to accelerate the development of safer, more effective treatments for childhood cancers using genomics and data science. This move aims to tailor therapies to individual tumour characteristics, reducing toxicity and improving outcomes for young patients. The programme highlights the growing trend in precision medicine and underscores the role of philanthropic funding in advancing high-risk research.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
13
Ali NematiWritten by Ali
